abpro.comHealthcare / BioTech & PharmaFounded: 2004Funding to Date: $69.53MM
Abpro leverages synthetic biology and immunology to accelerate antibody discovery and development in the life sciences industry.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/30/2022 | Series F | $2MM | $xx.xx | $628.78MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
111,111
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/03/2020 | Series E | $30MM | $xx.xx | $276.96MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,303,966
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/15/2020 | Series D | $18.2MM | $xx.xx | $245.47MM | Angelvest Group | |
Price per Share
$xx.xx
Shares Outstanding
1,220,261
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Angelvest Group
|
||||||
03/11/2016 | Series C | $15.73MM | $xx.xx | $129.1MM | Essex Bio-Technology | |
Price per Share
$xx.xx
Shares Outstanding
2,005,687
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Essex Bio-Technology
|
||||||
08/11/2015 | Series B | $1.8MM | $xx.xx | $47.28MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
626,636
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/20/2007 | Series A | $1.8MM | $xx.xx | $8.98MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
19,254
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
100.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|